Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.87 |
| ▸ | MGAM | O43451 | 4/20 | 0.87 |
| ▸ | AGL | P35573 | 3/20 | 0.57 |
| ▸ | GBA1 | P04062 | 4/20 | 0.50 |
| ▸ | SI | P14410 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LCT | P09848 | 1/20 | 0.50 |
| ▸ | GBA2 | Q9HCG7 | 7/20 | 0.48 |
| ▸ | UGCG | Q16739 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6135276 | 1.00 | GAA (0.87) | GAAMGAMAGLGBA1SI | |
| SCHEMBL6135315 | 1.00 | GAA (0.87) | GAAMGAMAGLGBA1SI | |
| SCHEMBL6135563 | 1.00 | GAA (0.87) | GAAMGAMAGLGBA1SI | |
| SCHEMBL10824953 | 1.00 | GAA (0.87) | GAAMGAMAGLGBA1SI | |
| Hydrochloric Acid SCHEMBL7623702 | 0.98 | GAA (0.83) | GAAMGAMAGLGBA1SI | |
| SCHEMBL23503296 | 0.93 | GAA (1.00) | GAAMGAMAGLGBA1SI | |
| SCHEMBL2434604 | 0.93 | GAA (1.00) | GAAMGAMAGLGBA1SI | |
| SCHEMBL8262434 | 0.93 | GAA (1.00) | GAAMGAMAGLGBA1SI | |
| SCHEMBL19227865 | 0.93 | GAA (1.00) | GAAMGAMAGLGBA1SI | |
| SCHEMBL11159128 | 0.93 | GAA (1.00) | GAAMGAMAGLGBA1SI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0322395-B1 | HETEROCYCLIC COMPOUNDS FOR INHIBITING VIRUS | Monsanto Company (US) | 1993-03-24 | — | — | EP | claimed |
| EP-0322395-A1 | Heterocyclic compounds for inhibiting virus | Monsanto Company (US) | 1989-06-28 | — | — | EP | claimed |
| US-20230345893-A1 | LETTUCE NAMED CARRIZO | VILMORIN-MIKADO USA, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20070179100-A1 | Protected monomers | ALNYLAM PHARMACEUTICALS, INC. | 2007-08-02 | — | — | US | disclosed |
| EP-0322395-B1 | HETEROCYCLIC COMPOUNDS FOR INHIBITING VIRUS | Monsanto Company (US) | 1993-03-24 | — | — | EP | disclosed |
| EP-0322395-A1 | Heterocyclic compounds for inhibiting virus | Monsanto Company (US) | 1989-06-28 | — | — | EP | disclosed |
| EP-0322395-A1 | Heterocyclic compounds for inhibiting virus | Monsanto Company (US) | 1989-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179100-A1 | Protected monomers | PCNA, POLN, PARP1 | GAA 2328/4885MGAM 1105/4885AGL 2874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.